On October 10, 2022, in Wondfo was successfully held the awards ceremony of the AIDS Prevention and Control Center by the Healthy China Engineering Management Committee. Yan Xiaozheng, director and secretary-general of the Healthy China Engineering Management Committee, delivered a speech at the scene. As the establishment of the center marks an appreciation of Wondfo Biotech’s constant efforts in AIDS prevention and control with technologies, Wondfo, by the chance of Healthy China Initiative, will comprehensively carry out AIDS awareness raising, intervention and testing. With a robust panel of HIV screening tests of triple sample types—blood, saliva, and urine—we strive to make it applicable to diagnose AIDS infection in multiple scenarios. In this way, we practically facilitate AIDS prevention and control domestically.

HIV Test Panel of Trinity Samples
Empower AIDS Control with Accessible Testing

According to the latest report on HIV/AIDS from the UNAIDS, there is an estimated 1.5 million new HIV infections in 2021 and 650,000 AIDS-related deaths in 2021.
 
In order to facilitate deployments of the CPC Central Committee and the State Council and to realize the sustainable development goal to end AIDS by 2030, 10 departments including the National Health Commission jointly formulated the Plan for Curbing the Spread of AIDS (2019-2022). It requires further progress in six major projects including comprehensive awareness raising of AIDS prevention, expanded testing and treatment, comprehensive social management, elimination of mother-to-child transmission, and AIDS prevention education for students.


At the awards ceremony, Yan Xiaozheng, director and secretary-general of the Healthy China Engineering Management Committee, appreciated Wondfo's constant efforts in AIDS prevention and control with technologies, and expressed his expectation for the AIDS Prevention and Control Center of the Healthy China Engineering Management Committee (hereinafter referred to as "AIDS Prevention and Control Center"). Li Wenmei, President of Wondfo Biotech expressed thankfulness for the trust from Healthy China Project and the confidence to continue to assist in the national AIDS prevention and control.
 
On the context of the establishment of the AIDS prevention and control center, Wondfo Biotech will form a panel of AIDS rapid tests of triple sample types (covering blood, saliva, urine) with existing platform and products. In this way, we make HIV testing “within reach” through awareness-raising publicity, intervention and testing, broadening channels for consultancy and emergent testing.
 

Wondfo HIV Tests Prequalified by WHO
Safeguard Health of Hundreds of Millions with Cutting-Edge Technology

As early as 2002, Wondfo launched the first HIV test, and then continued to enrich HIV tests with scientific research and innovation to support the global AIDS prevention and treatment. Relevant technical achievements and products have been widely recognized and used in more than 50 countries and regions around the world, safeguarding health of hundreds of millions of people.
 
On November 29, 2018, Wondfo HIV Test (for professional use) was prequalified by WHO; then, on July 13, 2022, Wondfo HIV Self-Test obtained prequalification, too. The performance of Wondfo HIV tests and the corporate quality system have been recognized by the WHO.

 
At the same time, Wondfo Biotech has been actively involved in public charitable activities for AIDS prevention, taking the social responsibility of technology enterprises with practices. Over the years, Wondfo, together with charitable institutions, has actively held charitable activities such as publicity of AIDS prevention and distribution HIV self-tests so as to accelerate AIDS prevention in community and campus, to eliminate prejudice against those infected with HIV and to facilitate scientific AIDS prevention.
 
The establishment of the AIDS prevention and control center in Wondfo Biotech is both a recognition and an expectation for Wondfo Biotech's active efforts in AIDS prevention and control. Wondfo will strengthen on- and off-line diagnosis and treatment, integrate treatment with prevention and facilitate a new med-ecosystem of AIDS prevention and control.
 
Fueled by innovation, Wondfo Biotech keeps in mind the original intention to provide the public with products of cutting-edge technologies and to support the global AIDS prevention and control with better products and services. In this way, we will jointly achieve the goal to end AIDS by 2030. Racing for Life.